Overview on ligands for the targeting in treatment of glioblastoma
Sachin D Chaudhari, Pankaj P Nerkar
Abstract:
Glioblastoma is a grade IV malignant primary central nervous system tumor with poor prognosis. Radiotherapy chemotherapy, surgical resection are the current therapies use for the management of GBM, but it can also cause dangerous side effects hence targeted therapies are in development. In targeted therapies, receptor targeted drug delivery is one of the most successful strategy. A receptor which are more express over the cancerous tissue or blood brain barrier that can be easily targeted and it is advantage to differentiate cancerous tissue and normal tissue. We summaries receptor targeted therapies and reagent used for conjugating or coupling ligand to drug.
Keywords: Glioblastoma, Single Receptor Targeting, Dual Receptor Targeting, Transferrin, Lactoferrin, Folic Acid.